Get a glimpse into our company and investor data—powered by the PitchBook Platform
Series FLATEST DEAL TYPE
$9.8MLATEST DEAL AMOUNT
Developer of catheter-based mitral valve repair system. The company has developed direct transcatheter annuloplasty system designed to treat both functional mitral regurgitation and tricuspid regurgitation.